Azaserine
File:Azaserine.png | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C5H7N3O4 |
Molar mass | 173.127 g/mol |
WikiDoc Resources for Azaserine |
Articles |
---|
Most recent articles on Azaserine |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Azaserine at Clinical Trials.gov Clinical Trials on Azaserine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Azaserine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Azaserine Discussion groups on Azaserine Directions to Hospitals Treating Azaserine Risk calculators and risk factors for Azaserine
|
Healthcare Provider Resources |
Causes & Risk Factors for Azaserine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Azaserine is a carcinogen primarily used for researching pancreatic cancer in animal models. It is a glutamine analogue that inhibits glutamine phosphoribosyl amidotransferase, which is involved in the synthesis of purine nucleotides.
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Amino acids
- Azo compounds
- IARC Group 2B carcinogens